---
title: "Protagonist announces Takeda received U.S. FDA approval for MIMRYLO"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297455451.md"
description: "Protagonist announces Takeda received U.S. FDA approval for MIMRYLO"
datetime: "2026-08-31T02:50:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297455451.md)
  - [en](https://longbridge.com/en/news/297455451.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297455451.md)
generator: "portal-rs"
---

# Protagonist announces Takeda received U.S. FDA approval for MIMRYLO


### Related Stocks

- [PTGX.US](https://longbridge.com/en/quote/PTGX.US.md)
- [TAK.US](https://longbridge.com/en/quote/TAK.US.md)
- [4502.JP](https://longbridge.com/en/quote/4502.JP.md)

## Related News & Research

- [How Investors Are Reacting To Protagonist Therapeutics (PTGX) Turning ICOTYDE Milestones Into Q2 Profit](https://longbridge.com/en/news/298232620.md)
- [Protagonist Therapeutics CEO Dinesh V. Patel disposes of common shares worth USD 18.25 million](https://longbridge.com/en/news/298662260.md)
- [Weekly Recap: Mimrylo approved for Polycythemia Vera and zasocitinib NDA](https://longbridge.com/en/news/298967403.md)
- [Oriola expands Nordic distribution partnership with Takeda in Finland](https://longbridge.com/en/news/298705251.md)
- [Scholar Rock announces FDA approval of isembyld](https://longbridge.com/en/news/298786115.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**